文献速递前列腺癌

去势抵抗性前列腺癌液体活检中雄激素受体的全面分析揭示新的AR基因内结构变异及剪接变异体表达模式

Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns.
PubMed 文献 · Eur Urol · 2017-01-16

本研究对30例去势抵抗性前列腺癌患者在新一轮系统治疗前采集外周血,通过低深度全基因组测序和靶向测序分析循环肿瘤DNA的AR基因(含内含子),并对富集循环肿瘤细胞组分行靶向RNA测序评估7种AR剪接变异体表达。结果显示25/30例检出任何AR扰动,15/30例存在AR基因内结构变异(其中14例表达ARVs),任何ARV的存在与二线内分泌治疗后的无进展生存期相关(HR 4.53,95%CI 1.424-14.41;p=0.0105)。

要点

  • 25/30例去势抵抗性前列腺癌患者液体活检中检出任何AR扰动(含ARVs)。
  • 15/30例存在AR基因内结构变异,其中14例表达ARVs;AR-V3表达最丰富。
  • 任何ARV的存在与二线内分泌治疗后无进展生存期相关(HR 4.53,95%CI 1.424-14.41;p=0.0105)。

核心结论

  • 基于液体活检的全面AR分析可行,对于增进对内分泌治疗耐药机制的理解是必要的。
  • 任何ARV的存在与二线内分泌治疗后的无进展生存期相关(HR 4.53,95%CI 1.424-14.41;p=0.0105)。

研究设计与样本

  • 来自去势抵抗性前列腺癌患者(n=30)在新一轮系统治疗开始前采集外周血。
  • 通过低深度全基因组测序和靶向测序分析循环肿瘤DNA的整个AR基因(包括内含子)。
  • 对富集循环肿瘤细胞组分行靶向RNA测序评估7种AR剪接变异体(ARVs)的表达水平。

主要发现

  • 任何AR扰动(包括ARV)在25/30例患者中检出。
  • AR基因内结构变异存在于15/30例患者,其中14例表达ARVs。
  • 大多数ARV阳性患者表达多种ARVs,AR-V3表达最丰富。
  • 17例不良缓解者中6例为AR-V7阴性,但其中4例携带其他AR扰动。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 随访研究需要确定此类改变对激素治疗的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Expression of the androgen receptor splice variant 7 (AR-V7) is associated with poor response to second-line endocrine therapy in castration-resistant prostate cancer (CRPC). However, a large fraction of nonresponding patients are AR-V7-negative. OBJECTIVE: To investigate if a comprehensive liquid biopsy-based AR profile may improve patient stratification in the context of second-line endocrine therapy. DESIGN, SETTING, AND PARTICIPANTS: Peripheral blood was collected from patients with CRPC (n=30) before initiation of a new line of systemic therapy. We performed profiling of circulating tumour DNA via low-pass whole-genome sequencing and targeted sequencing of the entire AR gene, including introns. Targeted RNA sequencing was performed on enriched circulating tumour cell fractions to assess the expression levels of seven AR splice variants (ARVs). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Somatic AR variations, including copy-number alterations, structural variations, and point mutations, were combined with ARV expression patterns and correlated to clinicopathologic parameters. RESULTS AND LIMITATIONS: Collectively, any AR perturbation, including ARV, was detected in 25/30 patients. Surprisingly, intra-AR structural variation was present in 15/30 patients, of whom 14 expressed ARVs. The majority of ARV-positive patients expressed multiple ARVs, with AR-V3 the most abundantly expressed. The presence of any ARV was associated with progression-free survival after second-line endocrine treatment (hazard ratio 4.53, 95% confidence interval 1.424-14.41; p=0.0105). Six out of 17 poor responders were AR-V7-negative, but four carried other AR perturbations. CONCLUSIONS: Comprehensive AR profiling, which is feasible using liquid biopsies, is necessary to increase our understanding of the mechanisms underpinning resistance to endocrine treatment. PATIENT SUMMARY: Alterations in the androgen receptor are associated with endocrine treatment outcomes. This study demonstrates that it is possible to identify different types of alterations via simple blood draws. Follow-up studies are needed to determine the effect of such alterations on hormonal therapy.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. De Laere B, van Dam PJ, Whitington T, et al. Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns. Eur Urol. 2017. PMID: 28104311. doi:10.1016/j.eururo.2017.01.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。